Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1
Andrei A. Pochtovyi, Daria D. Kustova, Andrei E. Siniavin, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1533-1533
Open Access | Times Cited: 20

Showing 20 citing articles:

Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 17
Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients
Inga Tometten, Tobias Brandt, Maike Schlotz, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Remdesivir and Obeldesivir Retain Potent Antiviral Activity Against SARS-CoV-2 Omicron Variants
Lauren Rodriguez, J. Lizbeth Reyes Zamora, Dong Han, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 168-168
Open Access
Decoding SARS-CoV-2 variants: Mutations, viral stability, and breakthroughs in vaccines and therapies
Zainularifeen Abduljaleel
Biophysical Chemistry (2025) Vol. 320-321, pp. 107413-107413
Closed Access
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges
Daniele Focosi, David J. Sullivan, Massimo Franchini
Expert Review of Anti-infective Therapy (2025)
Closed Access
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants?
Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 354-354
Open Access | Times Cited: 3
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation
Saskia C. Stein, Guido Hansen, George Ssebyatika, et al.
Journal of Virology (2024)
Open Access | Times Cited: 3
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 3
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 2
Exploring the Interplay of Mutations, Viral Stability, and Implications for Innovative Vaccination Strategies and Therapeutic Approaches Among Various SARS-CoV-2 Variants
Zainularifeen Abduljaleel
Research Square (Research Square) (2024)
Open Access
Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity
Roman Akasov, Olga E. Chepikova, Тatiana Pallaeva, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 5, pp. 130582-130582
Closed Access
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases
Bo-Wen Shiau, Wan‐Hsuan Hsu, Ya‐Wen Tsai, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 11, pp. 977-985
Closed Access
Investigation of severe acute respiratory syndrome coronavirus 2 infection status in solid organ transplant recipients treated with tixagevimab/cilgavimab
Ririka Aihara, Keisuke Umemura, Y. Katada, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 12, pp. 1222-1227
Closed Access
A prediction of mutations in infectious viruses using artificial intelligence
Won Jong Choi, Jongkeun Park, Do Young Seong, et al.
Research Square (Research Square) (2024)
Closed Access
The Molecular and Biological Patterns Underlying Sustained SARS-CoV-2 Circulation in the Human Population
Daria D. Kustova, Andrei A. Pochtovyi, Olga G. Shpakova, et al.
Problems of Virology (2024) Vol. 69, Iss. 4, pp. 329-340
Open Access
A prediction of mutations in infectious viruses using artificial intelligence
Won Jong Choi, Jongkeun Park, Do Young Seong, et al.
Genomics & Informatics (2024) Vol. 22, Iss. 1
Open Access
Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development
Xinkang Huan, Jiuyu Zhan, Hongwei Gao
Frontiers in Immunology (2024) Vol. 15
Open Access
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement
Elena Criscuolo, Benedetta Giuliani, Matteo Castelli, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
ANTIGENIC FEATURES OF THE STRAINS SARS-COV-2 OF OMICRON SUBLINES ASSESSED BY HYPERIMMUNE MOUSE SERUM NEUTRALISATION
Anna V. Zaykovskaya, В. А. Евсеенко, S. E. Olkin, et al.
Russian Journal of Infection and Immunity (2024)
Open Access
Modified micro test tubes as a promising basis for immobilization of antibodies for immunocapture on the example of SARS-CoV-2
EO Roubalsky, R. O. Abdrakhmanova, G. R. Baeva, et al.
Bulletin of Russian State Medical University (2024), Iss. 2024(6)
Open Access
Page 1

Scroll to top